InvestorsHub Logo
Followers 19
Posts 791
Boards Moderated 0
Alias Born 05/10/2009

Re: pennystockguru2011 post# 228

Friday, 10/14/2011 9:51:08 AM

Friday, October 14, 2011 9:51:08 AM

Post# of 113651
Liking this part from the PR also.

There are two genes associated with aggressive forms of breast cancer, Her2 and Top2. Herceptin, a drug marketed by Roche, is effective for Her2 positive patients, driving sales of roughly $1.8 billion annually. With no effective therapy for Top2, Adva-27a is likely to be granted fast-track designation, especially since it could help terminally ill patients. The drug has been undergoing pre-clinical trials, with very positive results.

Read more: http://www.beaconequity.com/sunshine-biopharma-inc-sbfm-to-fill-gap-in-cancer-treatment-2011-10-12/#ixzz1alPmKNB5

Go SBFM!

LW

Everything I write is my opinion only. My posts are not advice to be used for a investment decision.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News